C07D233/52

METHODS AND COMPOSITIONS FOR TREATING CANCER
20220370434 · 2022-11-24 ·

Provided, inter alia, are methods and compositions for treating FTO-mediated cancer.

METHODS AND COMPOSITIONS FOR TREATING CANCER
20220370434 · 2022-11-24 ·

Provided, inter alia, are methods and compositions for treating FTO-mediated cancer.

ORGANIC ELECTROLUMINESCENCE DEVICE AND DIAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
20220344589 · 2022-10-27 ·

An organic electroluminescence device of an embodiment includes a first electrode, a hole transport region disposed on the first electrode, an emission layer disposed on the hole transport region, an electron transport region disposed on the emission layer, and a second electrode disposed on the electron transport region, wherein the hole transport region includes a diamine compound represented by Formula 1, thereby showing high emission efficiency:

##STR00001##

MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS
20170362270 · 2017-12-21 ·

Modified oligonucleotides that contain one or more of the phosphate groups substituted at phosphorus and methods for their synthesis are disclosed.

Modified oligonucleotides and methods for their synthesis

The present invention is directed to modified oligonucleotides having the following Formula (I) ##STR00001##
wherein one or more of phosphate groups are substituted at phosphorus, and methods for their synthesis. The modified oligonucleotides are useful for diagnostic applications involving sequence specific recognition of a nucleic acid and for use in a method of medical treatment.

Manufacturing process for 2-nitroimino heterocyclic compounds

The present invention relates to a process for manufacture of 2-nitroimino heterocyclic compounds and intermediates thereof. More particularly, the present invention relates to a convenient manufacturing process for preparation of 2-nitroimino imidazolidine compounds.

Manufacturing process for 2-nitroimino heterocyclic compounds

The present invention relates to a process for manufacture of 2-nitroimino heterocyclic compounds and intermediates thereof. More particularly, the present invention relates to a convenient manufacturing process for preparation of 2-nitroimino imidazolidine compounds.

AMINOGUANIDINE HYDRAZONES AS RETROMER STABILIZERS USEFUL FOR TREATING NEUROLOGICAL DISEASES

The present invention relates to novel aminoguanidine hydrazone-derivatives of Formula (I) which are effective as retromer stabilizers and useful as neuroprotecting drugs. The invention also relates to pharmaceutical compositions comprising the compounds and their use in therapy and diagnostic.

##STR00001##

MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS
20210032283 · 2021-02-04 ·

Modified oligonucleotides that contain one or more of the phosphate groups substituted at phosphorus and methods for their synthesis are disclosed.

A Manufacturing Process for 2-Nitroimino Heterocyclic Compounds

The present invention relates to a process for manufacture of 2-nitroimino heterocyclic compounds and intermediates thereof. More particularly, the present invention relates to a convenient manufacturing process for preparation of 2-nitroimino imidazolidine compounds.